Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular Docking
ABSTRACT Background: Lonicerin (LON) has been identified to have different biological properties, such as anticancer, anti‐inflammatory, immunomodulatory, antibacterial, antimicrobial, and neuroprotective. This study aims to assess the sedative effect of LON in Swiss albino mice, which is yet to be...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Brain and Behavior |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/brb3.70524 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849718199297245184 |
|---|---|
| author | Tanzila Akter Eity Md. Shimul Bhuia Raihan Chowdhury Salehin Sheikh Siddique Akber Ansari Nowreen Tabassum Ahammed Hossam Kamli Muhammad Torequl Islam |
| author_facet | Tanzila Akter Eity Md. Shimul Bhuia Raihan Chowdhury Salehin Sheikh Siddique Akber Ansari Nowreen Tabassum Ahammed Hossam Kamli Muhammad Torequl Islam |
| author_sort | Tanzila Akter Eity |
| collection | DOAJ |
| description | ABSTRACT Background: Lonicerin (LON) has been identified to have different biological properties, such as anticancer, anti‐inflammatory, immunomodulatory, antibacterial, antimicrobial, and neuroprotective. This study aims to assess the sedative effect of LON in Swiss albino mice, which is yet to be discovered. Materials and Methods: Mice were treated with two different doses of LON (5 and 10 mg/kg) and 2 mg/kg of diazepam (DZP), which is the referral GABAergic medication, and the latency time and sleeping duration of animals were observed. A computational study was also conducted to evaluate the docking scores and display the binding sites of LON and receptor (GABAA α1 and β2 subunits). The study also investigated the pharmacokinetics and drug‐likeness properties of LON along with toxicological analysis by using SwissADME and Protox‐3 software, respectively. Results: Findings revealed that the higher concentration of LON reduced the latency (9.86 ± 1.44 min) and increased the sleep duration (191.29 ± 7.43 min) compared to the lower concentration. Besides, the combination group of LON and DZP showed the lowest latency (6.17 ± 0.82 min) and highest sleeping time (219.00 ± 6.39 min). In the in silico study, LON exhibited a strong docking score (−8.1 kcal/mol) with the macromolecules, which is closer to the binding affinity of DZP (–8.3 kcal/mol), indicating that LON could show strong sedative activity by binding with the GABAA receptor. Computational toxicity analysis revealed that LON is non‐hepatotoxic, non‐neurotoxic, noncarcinogenic, noncytotoxic, non‐ecotoxic, and non‐mutagenic. Conclusion: Therefore, LON may be effective for the treatment of insomnia in the near future. |
| format | Article |
| id | doaj-art-0f577e29d2c84078ad1dbc1743502eb2 |
| institution | DOAJ |
| issn | 2162-3279 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Wiley |
| record_format | Article |
| series | Brain and Behavior |
| spelling | doaj-art-0f577e29d2c84078ad1dbc1743502eb22025-08-20T03:12:26ZengWileyBrain and Behavior2162-32792025-05-01155n/an/a10.1002/brb3.70524Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular DockingTanzila Akter Eity0Md. Shimul Bhuia1Raihan Chowdhury2Salehin Sheikh3Siddique Akber Ansari4Nowreen Tabassum Ahammed5Hossam Kamli6Muhammad Torequl Islam7Department of Biotechnology and Genetic Engineering Gopalganj Science and Technology University Gopalganj BangladeshDepartment of Pharmacy Gopalganj Science and Technology University Gopalganj BangladeshDepartment of Pharmacy Gopalganj Science and Technology University Gopalganj BangladeshDepartment of Pharmacy Gopalganj Science and Technology University Gopalganj BangladeshDepartment of Pharmaceutical Chemistry College of Pharmacy King Saud University Riyadh Saudi ArabiaDepartment of Biology Touro University New York City New York USADepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences King Khalid University Abha Saudi ArabiaDepartment of Pharmacy Gopalganj Science and Technology University Gopalganj BangladeshABSTRACT Background: Lonicerin (LON) has been identified to have different biological properties, such as anticancer, anti‐inflammatory, immunomodulatory, antibacterial, antimicrobial, and neuroprotective. This study aims to assess the sedative effect of LON in Swiss albino mice, which is yet to be discovered. Materials and Methods: Mice were treated with two different doses of LON (5 and 10 mg/kg) and 2 mg/kg of diazepam (DZP), which is the referral GABAergic medication, and the latency time and sleeping duration of animals were observed. A computational study was also conducted to evaluate the docking scores and display the binding sites of LON and receptor (GABAA α1 and β2 subunits). The study also investigated the pharmacokinetics and drug‐likeness properties of LON along with toxicological analysis by using SwissADME and Protox‐3 software, respectively. Results: Findings revealed that the higher concentration of LON reduced the latency (9.86 ± 1.44 min) and increased the sleep duration (191.29 ± 7.43 min) compared to the lower concentration. Besides, the combination group of LON and DZP showed the lowest latency (6.17 ± 0.82 min) and highest sleeping time (219.00 ± 6.39 min). In the in silico study, LON exhibited a strong docking score (−8.1 kcal/mol) with the macromolecules, which is closer to the binding affinity of DZP (–8.3 kcal/mol), indicating that LON could show strong sedative activity by binding with the GABAA receptor. Computational toxicity analysis revealed that LON is non‐hepatotoxic, non‐neurotoxic, noncarcinogenic, noncytotoxic, non‐ecotoxic, and non‐mutagenic. Conclusion: Therefore, LON may be effective for the treatment of insomnia in the near future.https://doi.org/10.1002/brb3.70524Insomnialonicerinnatural productneuroprotectivepharmacokinetictoxicity |
| spellingShingle | Tanzila Akter Eity Md. Shimul Bhuia Raihan Chowdhury Salehin Sheikh Siddique Akber Ansari Nowreen Tabassum Ahammed Hossam Kamli Muhammad Torequl Islam Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular Docking Brain and Behavior Insomnia lonicerin natural product neuroprotective pharmacokinetic toxicity |
| title | Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular Docking |
| title_full | Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular Docking |
| title_fullStr | Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular Docking |
| title_full_unstemmed | Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular Docking |
| title_short | Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular Docking |
| title_sort | assessment of sedative activity of lonicerin in vivo approach with pharmacokinetics and molecular docking |
| topic | Insomnia lonicerin natural product neuroprotective pharmacokinetic toxicity |
| url | https://doi.org/10.1002/brb3.70524 |
| work_keys_str_mv | AT tanzilaaktereity assessmentofsedativeactivityoflonicerininvivoapproachwithpharmacokineticsandmoleculardocking AT mdshimulbhuia assessmentofsedativeactivityoflonicerininvivoapproachwithpharmacokineticsandmoleculardocking AT raihanchowdhury assessmentofsedativeactivityoflonicerininvivoapproachwithpharmacokineticsandmoleculardocking AT salehinsheikh assessmentofsedativeactivityoflonicerininvivoapproachwithpharmacokineticsandmoleculardocking AT siddiqueakberansari assessmentofsedativeactivityoflonicerininvivoapproachwithpharmacokineticsandmoleculardocking AT nowreentabassumahammed assessmentofsedativeactivityoflonicerininvivoapproachwithpharmacokineticsandmoleculardocking AT hossamkamli assessmentofsedativeactivityoflonicerininvivoapproachwithpharmacokineticsandmoleculardocking AT muhammadtorequlislam assessmentofsedativeactivityoflonicerininvivoapproachwithpharmacokineticsandmoleculardocking |